PR Newswire
STOCKHOLM, March 8, 2021 /PRNewswire/ — Elekta (EKTA-B.ST) announced today that the London Court of International Arbitration (LCIA) has awarded in favor of Elekta in a dispute with Livian GmbH (formerly humediQ GmbH).
The arbitration, reported in the latest interim report (Q3 2020/21), is now finally settled whereby all claims against Elekta group companies are rejected in full.
For further information, please contact:
Mattias Thorsson, VP Corporate Communications
Tel: +46 70 865 8012, e-mail: [email protected]
Time zone: CET: Central European Time
Cecilia Ketels, Head of Investor Relations
Tel: +46 76 611 76 25, e-mail: [email protected]
Time zone: CET: Central European Time
About Elekta
For almost five decades, Elekta has been a leader in precision radiation medicine. Our more than 4,000 employees worldwide are committed to ensuring everyone in the world with cancer has access to – and benefits from – more precise, personalized radiotherapy treatments. Headquartered in Stockholm, Sweden, Elekta is listed on NASDAQ Stockholm Exchange. Visit elekta.com or follow @Elekta on Twitter.
This information was brought to you by Cision http://news.cision.com
https://news.cision.com/elekta/r/elekta-wins-lawsuit-against-livian-gmbh,c3301556
The following files are available for download:
View original content:http://www.prnewswire.com/news-releases/elekta-wins-lawsuit-against-livian-gmbh-301242178.html
SOURCE Elekta
